What Is a Realistic Way to Combine Behavioural Signals with Clinical Judgement?
In today's healthcare landscape, the integration of digital behavioural signals with traditional clinical judgement is emerging as both a promising and challenging frontier. As more care delivery migrates to digital platforms—patient portals and remote monitoring systems becoming household names—clinicians and care teams are faced with interpreting a torrent of data that extends beyond vital signs and lab results, encompassing nuanced behavioural patterns captured in real time.
Successfully combining these behavioural signals with clinical expertise demands an approach grounded in realism, respect for privacy, and a focus on human oversight. Drawing on lessons from regulated industries such as gambling, as well as cutting-edge research like that from the National Institutes of Health (NIH), this post unpacks how health systems and solutions companies, including innovators like MrQ, can leverage digital interactions as early warning signs without succumbing to the pitfalls of overinterpretation or automated decision-making.

Why Behavioural Signals Matter in Healthcare
Behavioural risk factors do not emerge overnight—they appear gradually, embedded within patterns of digital interactions. Unlike discrete clinical events (for example, a sudden spike in blood pressure), behavioural signals surface across multiple touchpoints EHR alerts best practices over time, requiring a lens that looks at trends instead of snapshots.
Consider the use of patient portals or remote monitoring systems. These tools generate a wealth of engagement data:

- Frequency and timing of patient logins
- Responses to symptom questionnaires
- Medication adherence as logged by smart devices
- Alerts triggered by anomalous biometric readings
Individually, one missed login or a slightly elevated heart rate might not signify risk. But when these occurrences cluster or change in pattern—fewer logins over weeks combined with inconsistent medication adherence and emerging biometric anomalies—they can provide early signals of deteriorating health or emerging psychosocial challenges.
The Lessons from Regulated Platforms: Gambling Behaviour as an Early Warning
Outside healthcare, regulated platforms like gambling operators have long used behavioural signals as early warnings to prevent harm. These platforms analyze sequences and patterns—like increased bet sizes, chasing losses, or irregular playing times—to trigger human review and offer support or intervention before problem gambling escalates.
The key principle is that the data supports decision-making rather than replaces it. Automated flags lead to contextual, human-centred assessment: “What would support look like here?”
This approach is directly applicable to healthcare digital platforms. The goal isn't to label every drop-off in engagement as non-compliance or risk but to use behavioural trends to guide a contextual review by clinicians or trained support staff who can then make nuanced, patient-centred decisions.
Integrating Behavioural Signals with Clinical Judgement: A Realistic Model
Here is an outline of how combining behavioural signals with clinical judgement can be operationalized in a way that respects evidence and privacy:
- Continuous, Pattern-Based Monitoring: Use algorithms that identify concerning behavioural trends rather than single outlier events. For example, MrQ’s analytics platform aggregates patient portal activity over months to detect meaningful changes rather than reacting to isolated missed logins.
- Decision Support Tools, Not Automated Decisions: Present clinicians with contextualized behavioural risk alerts alongside clinical data within electronic health record (EHR) systems, enabling informed interpretation rather than automatic flagging.
- Human Oversight and Contextual Review: Commit to a workflow where alerts trigger a human assessment focused on “what would support look like here?” This approach was emphasized in NIH’s recent initiative on integrating digital phenotyping data responsibly.
- Privacy and Evidence Standards Must Lead: All behavioural data collection and usage should meet rigorous consent, privacy, and validation standards before influencing clinical decisions. Patients must understand and opt into how their digital interactions inform care.
Challenges and How to Address Them
Efforts to merge behavioural signals with clinical judgement often run into these hurdles:
- Confounding Correlation with Causation: Behavioural patterns may correlate with risk but not explain it. This requires clinicians to avoid premature conclusions and contextualize signals within the whole patient story.
- Privacy Concerns: Collecting and interpreting digital behaviour must avoid "privacy hand-waving." Patients need clear, granular choices about what data they share and how it is used in care decisions.
- Over-Reliance on Dashboards: Dashboards that celebrate clicks or view counts without clarifying confusion or uncertainty add noise and clinician burden. Tools must clearly distinguish signals (data points predictive of outcomes) from stories (interpretations subject to bias).
- Resistance to Human Review Paths: Shipping AI-driven features without a seamless human review option risks harm. Every alert or recommendation must be a prompt for a clinician or care worker’s judgement, never a final decision.
Strategies for Overcoming These Challenges
- Implement training programs focusing on signal vs story to help clinical teams distinguish data-driven insights from assumptions.
- Design patient portals and remote monitoring interfaces with embedded privacy controls and transparent notices about behavioural data use.
- Focus dashboard design on explanatory analytics that illuminate confusion and next steps rather than simply summarizing activity counts.
- Build clear escalation workflows integrating AI flags with mandatory human contextual review and documented decisions.
Looking Ahead: The Future of Decision Support Combining Behavioural and Clinical Data
Organizations like the National Institutes of Health are funding efforts to rigorously validate how digital behavioural phenotyping can complement traditional clinical assessments. Meanwhile, companies like MrQ are pioneering platforms that combine patient-reported outcomes with digital interaction data in a privacy-respecting, clinician-friendly manner.
The ideal future state is one where:
- Behavioural signal analytics aid early identification of at-risk patients before clinical deterioration becomes visible.
- Decision support tools empower clinicians with timely, validated insights supported by transparent, patient-approved data flows.
- Human oversight remains central, ensuring personalised, empathetic care instead of mechanistic triage.
- Privacy and ethical standards set the foundation for trust, enabling broader adoption and utility.
Conclusion
Combining behavioural signals with clinical judgement is not about replacing clinicians with algorithms, or turning every digital interaction into a risk flag. Instead, it is about leveraging gradual, pattern-based behavioural insights as a component of informed, patient-centered decision support—always underpinned by rigorous privacy and evidence standards, and centered on human oversight.
By learning from regulated sectors like gambling and guided by research from institutions such as the NIH, healthcare systems and innovators like MrQ can develop realistic, ethical models that harness the power of digital signals without losing sight of the person behind the data.
Ultimately, the question is not just “what do the signals say?” but “what would support look like here?”—a question demanding both the precision of data and the wisdom of human judgement.